EPO granted patent EP4212194A1 to Suzhou Savicred Biotechnology Co., Ltd. (inventors: WANG Jing, ZHOU Hongxia, SHEN Wei) on March 25, 2026, covering a syringe protection device and safe syringe under IPC classification A61M 5/178. The patent designates 36 contracting states covering the EU and associated European countries.\n\nCompetitors manufacturing or developing injection safety devices should conduct freedom-to-operate analysis to assess potential infringement risks. Companies developing similar syringe protection mechanisms should review the patent claims for design-around opportunities. Parties seeking to use this technology should explore licensing options with the patent holder.